The Strategic Plan for Control of Tuberculosis in Australia, 2016–2020: Towards Disease Elimination
DOI:
https://doi.org/10.33321/cdi.2019.43.10Keywords:
strategic plan, tuberculosis, eliminationAbstract
This document has been prepared by NTAC as the Strategic Plan for the next 5 years to improve TB control and provide a push towards the elimination of TB in Australia. It will be used as a basis for developing a specific NTAC work plan for 2016-2020. This Strategic Plan aligns with international priorities, and includes a range of activities which will require further consideration within various jurisdictions, government agencies and other organisations. It is expected, therefore, that relevant organisations, including state and territory TB Programs, will similarly make use of the document to guide and prioritise activities relating to TB over this period.
Downloads
References
Australian Bureau of Statistics. 3412.0 - Migration, Australia, 2014-15 2016. Accessed on 24 October 2016. Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3412.0
Toms C, Stapledon R, Waring J, Douglas P, National Tuberculosis Advisory Committee for the Communicable Diseases Network Australia, and the Australian Mycobacterium Reference Laboratory Network. Tuberculosis notifications in Australia, 2012 and 2013. Commun Dis Intell 2015;39(2).
World Health Organization. Global Tuberculosis Report 2016. 2016. Accessed on 24 October 2016. Available from: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1
World Health Assembly. Sixty-Seventh World Health Assembly, Resolution and Decisions Annexes, WHA67.1 - Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva, Switzerland: World Health Organization; 2014. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf#page=25
World Health Organization. The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015. 2014. Accessed on 20 October 2016. Available from: http://www.who.int/tb/strategy/End_TB_Strategy.pdf?ua=1
World Health Organization. Towards tuberculosis elimination: an action framework for low-incidence countries. 2014. Accessed on 20 October 2016. Available from: http://apps.who.int/iris/bitstream/10665/132231/1/9789241507707_eng.pdf?ua=1
Lonnroth K, Migliori GB, Abubakar I, D’Ambrosio L, de Vries G, Diel R, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015;45(4):928-952.
World Health Organization. WHO treatment guidelines for drug resistant tuberculois: 2016 update. 2016. Accessed on 24 October 2016. Available from: www.who.int/tb/areas-of-work/drug-resistant-tb/treatment/resources/
Commonwealth of Australia. Tuberculosis Act 1948. In.
State of New South Wales. Tuberculosis Acts of 1949, 1958, 1965 and 1970. In.
State of Queensland. The Tuberculosis Agreement Acts of 1949, 1958, 1964 and 1969. In.
State of Western Australia. Tuberculosis (Commonwealth and State Arrangement) Acts of 1949, 1958 and 1965. In.
State of Tasmania. Tuberculosis (Campaign Arrangements) Act 1950. In.
State of Victoria. Health (Tuberculosis Arrangement) Acts of 1949, 1960, 1965 and 1971. In.
State of South Australia. Tuberculosis (Commonwealth Arrangement) Act of 1949. In.
Condrau F, Worboys M. Tuberculosis Then and Now: Perspectives on the History of an Infectious Disease: McGill-Queen’s Press - MQUP; 2010.
Proust AJ. History of Tuberculosis in Australia, New Zealand and Papua New Guinea. Canberra, A.C.T: Brolga Press; 1991.
Li J, Roche P, Spencer J, Bastian I, Christensen A, Hurwitz M, et al. Tuberculosis notifications in Australia, 2003. Commun Dis Intell Q Rep 2004;28(4):464-473.
Australian Government Department of Health. Responding to the threat of antimicrobial resistance: Australia’s first national antimicrobial resistance strategy, 2015-2019. Canberra: Commonwealth of Australia; 2015. Available from: https://www.amr.gov.au/resources/national-amr-strategy
Department of Health. About the National Tuberculosis Advisory Committee (NTAC). 2015. Accessed on October 2015. Available from: http://www.health.gov.au/ntac
National Tuberculosis Advisory Committee of Communicable D. The strategic plan for control of tuberculosis in Australia: 2011-2015. Commun Dis Intell Q Rep 2012;36(3):E286-293.
Lumb R. Future reporting of tuberculosis in Australia. Commun Dis Intell Q Rep 2014;38(4):E375.
National Tuberculosis Advisory C. Position statement on interferon-gamma release assays in the detection of latent tuberculosis infection. Commun Dis Intell Q Rep 2012;36(1):125-131.
Position statement on interferon-gamma release assays in the detection of latent tuberculosis infection. Commun Dis Intell Q Rep 2012;36(1):125-131.
The BCG vaccine: information and recommendations for use in Australia. National Tuberculosis Advisory Committee update October 2012. Commun Dis Intell Q Rep 2013;37(1):E65-72.
Essential components of a tuberculosis control program within Australia. Commun Dis Intell Q Rep 2014;38(4):E397-400.
Krause V. Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention. Commun Dis Intell Q Rep 2015;39(4):E597-598.
Kickbush I, Bucket K Ed. Implementing Health in All Policies: Adelaide 2010. 2010.
Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330(24):1710-1716.
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City--turning the tide. N Engl J Med 1995;333(4):229-233.
Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 2014;11(7):e1001675.
Doyle JS, Bissessor M, Denholm JT, Ryan N, Fairley CK, Leslie DE. Latent Tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile? J Acquir Immune Defic Syndr 2014;66(1):48-54.
Levy MH, Butler TG, Zhou J. Prevalence of Mantoux positivity and annual risk of infection for tuberculosis in New South Wales prisoners, 1996 and 2001. N S W Public Health Bull 2007;18(7-8):119-124.
World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. 2014. Accessed on 05/11/2015. Available from: http://www.who.int/tb/post2015_strategy/en/
Denholm JT, McBryde ES. Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting. Aust N Z J Public Health 2014;38(1):78-82.
Communicable Disease Network Australia. Tuberculosis: CDNA National Guidelines for the Public Health Management of TB. 2013. Accessed on 4 November 2015. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/D140EDF48C0A0CEACA257BF0001A3537/$File/TB-2.0-april2015.pdf
Getahun H, Matteelli A, Abubakar I, Abdel Aziz M, Baddeley A, Barreira D, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal 47(6).
Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000;162(6):2033-2038.
McBryde ES, Denholm JT. Risk of active tuberculosis in immigrants: effects of age, region of origin and time since arrival in a low-exposure setting. Med J Aust 2012;197(8):458-461.
Australian Government Department of Health. Medicare Benefits Schedule Book: Operating from 01 July 2016. 2016. Accessed on 24 October 2016. Available from: http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/1BC94358D4F276D3CA257CCF0000AA73/$File/201607-MBS.pdf
Denholm JT, Matteelli A, Reis A. Latent tuberculous infection: ethical considerations in formulating public health policy. Int J Tuberc Lung Dis 2015;19(2):137-140.
World Health Organization. Antimicrobial resistance: global report on surveillance 2014; 2014. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/
World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization; 2015. Available from: https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1&isAllowed=y
Communicable Diseases Network Australia. Tuberculosis case definition. 2011. Accessed on October 2015. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_tb.htm
Communicable Diseases Network Australia. National Notifiable Diseases Surveillance System. 2015. Accessed on March 2015. Available from: www.health.gov.au/nndssdata
Public Health Laboratory Network. Tuberculosis Laboratory Case Definition (LCD). 2006. Accessed on October 2015. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-phlncd-tb.htm
Lonnroth K, Migliori GB, Raviglione M. Toward tuberculosis elimination in low-incidence countries: reflections from a global consultation. Ann Intern Med 2014;161(9):670-671.
Nguyen HT, Hickson RI, Kompas T, Mercer GN, Lokuge KM. Strengthening tuberculosis control overseas: who benefits? Value Health 2015;18(2):180-188.
Published
How to Cite
License
Copyright (c) 2019 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
